Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Why keto appears to lower blood pressure for some people but not others

17

Aug 2026

Why keto appears to lower blood pressure for some people but not others

A narrative review finds that ketogenic diets may modestly lower blood pressure through weight loss, reduced visceral fat, improved insulin sensitivity, fluid and electrolyte shifts, and anti-inflammatory effects. However, effects vary across studies, long-term cardiovascular evidence remains limited, and diet quality, hydration, electrolyte balance, and medication monitoring are important.

Food fraud costs the UK up to £2 billion a year

17

Aug 2026

Food fraud costs the UK up to £2 billion a year

Researchers developed the first model to estimate the total annual economic cost of food fraud in the UK, placing it between £0.4 billion and £2 billion. Although food fraud appears relatively rare, individual crime schemes can cause substantial harm, with businesses bearing most costs and strong quality controls helping protect major supply chains.

A Mediterranean ingredient gave gluten-free pasta an unexpected upgrade

17

Aug 2026

A Mediterranean ingredient gave gluten-free pasta an unexpected upgrade

Researchers developed carob-enriched gluten-free tagliatelle that increased dietary fiber and antioxidant activity while reducing starch digestibility and improving pasta structure. A 20% carob substitution provided the best overall balance of functional properties, texture, and consumer acceptance, although clinical health benefits remain to be established.

What 720,000 adults reveal about artificial sweeteners and diabetes risk

16

Aug 2026

What 720,000 adults reveal about artificial sweeteners and diabetes risk

A meta-analysis of six prospective cohort studies involving 721,003 adults found that higher artificial sweetener intake was associated with a 31% greater risk of developing type 2 diabetes. The evidence was rated low certainty because of substantial heterogeneity, observational study designs, and potential residual confounding, meaning the findings do not establish causation.

What happens to body fat when people follow the Eatwell Guide?

16

Aug 2026

What happens to body fat when people follow the Eatwell Guide?

Higher adherence to the UK Eatwell Guide was associated with lower BMI, waist circumference, total body fat, and trunk fat in more than 156,000 UK Biobank participants. The associations persisted prospectively across demographic, physical activity, and genetic-risk groups, supporting the role of diet quality in weight management.

What happens to body fat when people follow the Eatwell Guide?

16

Aug 2026

What happens to body fat when people follow the Eatwell Guide?

Higher adherence to the UK Eatwell Guide was associated with lower BMI, waist circumference, total body fat, and trunk fat in more than 156,000 UK Biobank participants. The associations persisted prospectively across demographic, physical activity, and genetic-risk groups, supporting the role of diet quality in weight management.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.